| Product Name | NebuSelect™ Recombinant Human MAP3K8 Protein, 74-389aa, His-tag |
|---|---|
| Catalog Number | NBL-293872 |
| Alias/Synonyms | Mitogen-activated protein kinase kinase kinase 8, 2.7.11.25, Cancer Osaka thyroid oncogene, Proto-oncogene c-Cot, Serine/threonine-protein kinase cot, Tumor progression locus 2, TPL-2, MAP3K8, COT, ES |
| Appearance | see COA |
| Molecule Weight | 38 kDa |
| CAS | N/A |
| Solubility | N/A |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | See COA |
| Additional info 1 | Ship with Ice Pack. |
| Additional info 2 | For Research Use Only. |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-293872-100UG | 100ug | Inquire | In Stock | |
| NBL-293872-500UG | 500ug | Inquire | In Stock | |
| NBL-293872-1MG | 1mg | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human MAP3K8 Protein, 74-389aa, His-tag
Catalog Number:
NBL-293872
Description:
NebuSelect™ Recombinant Human MAP3K8 Protein, His-tag (Cat# NBL-293872) is expressed in E. coli with His Tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
Species:
Human
Expression System:
E. coli
Molecular Weight:
38 kDa
Target Name:
MAP3K8
Synonym:
Mitogen-activated protein kinase kinase kinase 8, 2.7.11.25, Cancer Osaka thyroid oncogene, Proto-oncogene c-Cot, Serine/threonine-protein kinase cot, Tumor progression locus 2, TPL-2, MAP3K8, COT, ESTF
Purity:
>90% by SDS-PAGE.
Formulation:
See COA
Endotoxin:
<1 EU/ug(LAL Method)
Storage:
4°C for short term; -20°C for long term.
To get more information, please contact us freely.